Oct4 contributes to progression of hepatocellular carcinoma via enhancement on tumor-initiating cell-like properties and epithelial-mesenchymal transition
碩士 === 國立陽明大學 === 臨床醫學研究所 === 100 === Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer-related death worldwide and the second one in Taiwan. Because of high mortality and poor prognosis of this cancer, more effective treatment, in addition to surgery and current target therapy, is...
Main Authors: | Yu-Hsuan Hung, 洪妤萱 |
---|---|
Other Authors: | Jaw-Ching Wu |
Format: | Others |
Language: | en_US |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/47147268234999772275 |
Similar Items
-
Oct4 mediates tumor initiating properties in oral squamous cell carcinomas through the regulation of epithelial-mesenchymal transition.
by: Lo-Lin Tsai, et al.
Published: (2014-01-01) -
Overexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
by: Jian Wang, et al.
Published: (2011-01-01) -
Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma
by: Deng-Yong Zhang, et al.
Published: (2020-08-01) -
Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
by: Jaewhan Song
Published: (2020-10-01) -
14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
by: Tzu-An Liu, et al.
Published: (2013-01-01)